Supportive Oligonucleotide Therapy (SOT)
SOT is a personalised therapy for cancer, viruses and pathogens including Lyme Disease. The SOT has the ability to bind to a specific gene of interest that controls the cancer cell or pathogen by disrupting the critical process that promotes its survival or growth. During this therapy, we analyse a patient’s blood and we create a complementary oligonucleotide sequence that is designed to interrupt survival or growth of the cells. RGCC SOTs are available to RGCC Network doctors. Please contact us to discuss your requirements.
No. 9, Wisma Laxton, Jalan Desa,
Taman Desa,
58100 Kuala Lumpur, Malaysia.
Klang Branch
No 4, Jalan Astaka 1A/KU2
Bandar Bukit Raja 41050 Klang, Selangor
All Rights Reserved | WellLab
Designed by Trinity42